Mirabegron [Cas No. 223673-61-8] is a β3-adrenergic receptor agonist API widely used in treatment of urology. Mirabegron activates β3-adrenergic receptor in urinary bladder and helps in relaxation of detrusor muscle, resulting in increasing bladder storage capacity and reduces urinary urgency and frequency. Mirabegron treats overactive bladder [OAB] and is widely utilised in metabolic research and is key component that targets obesity, weight management as well as metabolic syndrome.
Chemox Pharma manufacturers high purity Mirabegron API in IP/BP/EP/USP standards. We offer high-quality products with high levels of compliance. Our API products are trusted by pharmaceutical industries, which reflects our global footprints and reputation. Our facilities follow the standard regulations of the world like DCGI, WHO-GMP, FDA.
| Sr. No. | Description | Application |
|---|---|---|
| 1 | β3-adrenergic agonist API | Overactive bladder treatment formulations |
| 2 | Urology therapeutic drug substance | Urinary incontinence therapy |
| 3 | Bladder relaxant pharmaceutical ingredient | Urgency and frequency control drugs |
| 4 | Urological smooth muscle relaxant API | OAB symptom management |
| 5 | Selective β3 receptor agonist | Urinary tract disorder formulations |
Mirabegron is widely used by pharmaceutical manufacturers in formulations for overactive bladder and urinary dysfunction management.
Mirabegron API should be handled according to standard pharmaceutical material safety and industrial hygiene procedures. Appropriate protective measures must be followed during handling and processing of the urology active pharmaceutical ingredient in GMP manufacturing environments.
Use appropriate personal protective equipment (PPE)
Avoid inhalation of powder and contact with skin or eyes
Handle in controlled pharmaceutical manufacturing areas
Follow GMP material handling procedures
Refer to Safety Data Sheet (SDS) for detailed safety guidance
This API is intended exclusively for pharmaceutical manufacturing and formulation use.
Mirabegron is a selective β3-adrenergic receptor agonist that stimulates β3 receptors in the detrusor smooth muscle of the urinary bladder. Activation of these receptors promotes relaxation of bladder muscle during the storage phase, increasing bladder capacity and reducing urinary urgency and frequency. This mechanism supports its therapeutic use in overactive bladder and urinary incontinence management.
Handle in approved pharmaceutical manufacturing facilities
Avoid exposure without protective equipment
Prevent dust generation and inhalation
Follow GMP containment procedures
Dispose according to regulatory guidelines
Store in tightly closed containers
Protect from moisture and light
Maintain controlled room temperature
Keep in designated API storage areas
Follow GMP warehouse practices
<h3>What is Mirabegron API used for?</h3>
<p>Mirabegron API is used in pharmaceutical formulations for the treatment of overactive bladder and urinary incontinence by relaxing bladder smooth muscle.</p>
<h3>Is Chemox Pharma a Mirabegron API manufacturer in India?</h3>
<p>Yes, Chemox Pharma is a WHO-GMP certified Mirabegron API manufacturer and supplier in India serving global pharmaceutical companies.</p>
<h3>What is the CAS number of Mirabegron?</h3>
<p>The CAS number of Mirabegron API is 223673-61-8.</p>
<h3>What is the therapeutic class of Mirabegron API?</h3>
<p>Mirabegron belongs to the β3-adrenergic receptor agonist class of urology therapeutic agents used in overactive bladder management.</p>
<h3>How should Mirabegron API be stored?</h3>
<p>It should be stored in tightly closed containers at controlled room temperature, protected from moisture and light, following pharmaceutical storage guidelines.</p>
API name/end use: Bedaquiline Cas number: 5409-58-5 Molecular formula: C15H18ClNO Molecular Weight: 263.76 Appearance: White to off-white powder Storage: Room Temperature
Chemical name: 4-Amino-5-fluoro-1-[(2R,5S)-2-hydroxymethyl)-1,3-oxathiolan-5-yl]-2-(1H-pyrimidinone) Cas number: 143491-57-0 Molecular formula: C8H10FN3O3S Molecular weight: 247.24 Therapeutic uses: Nucleoside transcriptase inhibitor Specifications: IP/BP/USP Appearance: White to
Chemical name: (4S,6S)-4-(Ethyl amino)-5,6-dihydro-6-methyl-4H-thieno[2,3-b] thiopyran-2-sulfonamide 7,7-Dioxide Hydrochloride Cas number: 130693-82-2 Molecular formula: C10H16N2O4S3·HCl Molecular weight: 360.89 Therapeutic uses: Topical beta blockers Specifications: